Search for Clinical Trial Results

Sponsored By

Multiple Sclerosis, Relapsing-Remitting - 27 Studies Found

Status Study
Completed Study Name: An Observational Study for the Assessment of Compliance and Persistence to Rebif® Therapy of Patients With Relapsing-remitting Multiple Sclerosis (MS) and Evaluation of Potential Factors Influencing These Parameters
Condition: Multiple Sclerosis, Relapsing-Remitting
Date: 2010-04-26
Completed Study Name: A Study to Evaluate Rebif® New Formulation (Interferon-beta-1a) in Relapsing Remitting Multiple Sclerosis
Condition: Multiple Sclerosis, Relapsing-Remitting
Date: 2007-02-26
Interventions:
  • Drug: Rebif® New Formulation (IFN-beta-1a, RNF)

Completed Study Name: A Phase II Study Comparing Low- and High-Dose Alemtuzumab and High-Dose Rebif® in Patients With Early, Active Relapsing-Remitting Multiple Sclerosis
Condition: Multiple Sclerosis, Relapsing-Remitting
Date: 2002-12-19
Interventions:
  • Biological: Interferon beta-1a

Terminated Study Name: Minocycline as add-on to Interferon Beta-1a [IFN Beta-1a] (Rebif®) in Relapsing-Remitting Multiple Sclerosis [RRMS]
Condition: Multiple Sclerosis, Relapsing-Remitting
Date: 2010-05-28
Interventions:
  • Drug: Minocycline Participants
Completed Study Name: A Study of Rebif® Compared With Avonex® in the Treatment of Relapsing-remitting Multiple Sclerosis (MS)
Condition: Multiple Sclerosis, Relapsing-Remitting
Date: 2006-02-13
Interventions:
  • Drug: Rebif® Rebif®

Completed Study Name: Study to Assess Whether GSK239512 Can Remyelinate Lesions in Subjects With Relapsing Remitting Multiple Sclerosis
Condition: Multiple Sclerosis, Relapsing-Remitting
Date: 2013-01-17
Interventions:
  • Drug: GSK239512 White to almos
Completed Study Name: Melatonin in Relapsing-Remitting Multiple Sclerosis Patients
Condition: Multiple Sclerosis, Relapsing-Remitting
Date: 2011-01-18
Interventions: Drug: Melatonin 3mg oral, daily, one hour before sleep
Enrolling by invitation Study Name: Pilot Trial of Domperidone in Relapsing-Remitting Multiple Sclerosis (RRMS)
Condition: Multiple Sclerosis, Relapsing-Remitting
Date: 2015-07-02
Interventions: Drug: Domperidone Addition of Domperidone to current Disease Modifying Therapy.
Completed Study Name: Study Assessing Cognition in Relapsing Remitting Multiple Sclerosis (RRMS) Patients Treated With BG00012
Condition: Multiple Sclerosis, Relapsing-Remitting
Date: 2015-10-16
Interventions: Drug: dimethyl fumarate dimethyl fumarate administered as per the arm description
Completed Study Name: Participants Preferences to Disease Modifying Agents in Relapsing Remitting Multiple Sclerosis Condition
Condition: Multiple Sclerosis, Relapsing-Remitting
Date: 2015-11-04
Next >>>